Fig. 3
From: Serum and exosome WNT5A levels as biomarkers in non-small cell lung cancer
WNT5A levels in various fractions of the serum. A: The concentration of WNT5A protein in serum, supernatant, and exosomes. B: Distribution of WNT5A within exosomes in NSCLC and HC samples. Quantitative analysis of WNT5A levels in serum (C) and supernatant (D) among HC, LUAD and LUSC patients. E: WNT5A levels pg/particle as exosome surface F: WNT5A levels pg/particle as exosome surface + cargo